Structure via PubChem · Public domain (PubChem)
Chemical data
- Formula
- C14H14N2
- Molecular weight
- 210.27 g/mol
- IUPAC name
- 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole
- SMILES
- C1CN=C(N1)CC2=CC=CC3=CC=CC=C32
- InChIKey
- CNIIGCLFLJGOGP-UHFFFAOYSA-N
- XLogP
- 2.1
- Polar surface area
- 24.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 1
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1971
- Admin. routes
- topical
- Indications
- neoplasm, eye allergy, allergic conjunctivitis, common cold
via ChEMBL · EBI
Research
587 papers- Naphazoline intoxication managed with minimally invasive cardiac output monitoring.The American journal of emergency medicine · 2024
- Naphazoline intoxication with transient QT prolongation and acute myocardial injury.Journal of cardiology cases · 2024
- Naphazoline and oxymetazoline are superior to epinephrine in enhancing the cutaneous analgesia of lidocaine in rats.Fundamental & clinical pharmacology · 2023
- Naphazoline abuse: a rare case of myocardial infarction with nonobstructive coronary arteries.Journal of cardiovascular medicine (Hagerstown, Md.) · 2024
- Treatment of allergic rhinitis and allergic conjunctivitis.The Medical letter on drugs and therapeutics · 2025
via PubMed
Wikidata facts
- Subclass of
- heterocyclic compound
- Has part
- carbon
- Mass
- 210.115698
- Has use
- medication
Show 7 more facts
- chemical formula
- C₁₄H₁₄N₂
- World Health Organisation international non-proprietary name
- naphazoline
- medical condition treated
- sinusitis
- canonical SMILES
- C1CN=C(N1)CC2=CC=CC3=CC=CC=C32
- defined daily dose
- 0.4
- subject has role
- decongestant
- Commons category
- Naphazoline
Sources (3)
via Wikidata · CC0